SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (7313)1/23/2004 12:16:05 AM
From: rkrw  Read Replies (1) | Respond to of 10280
 
<<It is too early to tell if it is good or not>>

Not really or maybe we have different standards.

By my quick count sepr has spent $1.1B in r&d since 1998 with no drug approvals. This is for an ICE strategy! If sepr cont to be this inefficient they may as well sell the co. as soon as practical after estorra and mdi approval.